🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareGLP-1 for type 1 diabetes as adjunct — need advice Page 8

GLP-1 for type 1 diabetes as adjunct — need advice

SarahChen_PharmD Fri, Jan 31, 2025 at 10:02 PM 40 replies 1,803 viewsPage 8 of 8
NurseLeah_Nash
Member
278
1,234
Sep 2024
Nashville, TN
Aug 21, 2025 at 11:42 PM#36

Clinical perspective, offered as context rather than as advice. Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the correction. That is slower than asserting, and it is the only version that survives being wrong.

50 0RegAffairsDC, BiostatsBrad, PeptideSynthNJ and 47 others
Reply Quote Save Share Report
Dr.EndoEP
Member
267
1,234
Oct 2024
El Paso, TX
Sep 2, 2025 at 10:53 AM#37
NurseLeah_Nash said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Adding a me-too, because a thread of one person's experience is not much use.

Last edited: Sep 2, 2025 at 12:53 PM
49 24james_edin, FranDenver, Dr.BariatricHTX and 46 others
Reply Quote Save Share Report
maya_sedona
Member
289
1,234
Sep 2024
Sedona, AZ
Sep 13, 2025 at 9:58 PM#38
NurseLeah_Nash said:
Whatever the answer turns out to be, the method for getting there is the same: state the assumption, do the arithmetic in public, and invite the…

Coming at NurseLeah_Nash’s question from a different direction. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

Last edited: Sep 14, 2025 at 1:58 AM
48 23BenResearch_OR, MikeKY_noInsulin, Dr.RaviCardio and 45 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
LabKate
Senior Member
2,678
11,234
Jan 2024
Oregon
Sep 25, 2025 at 8:56 AM#39

Adding the numbers, since they settle part of this. Practical: whatever you change, write down the date and the reason. In three months the reason is what you will have forgotten, and the reason is what makes the record worth having.

47 22emily_PDX, Dr.SleepRoch, laura_annarbor and 44 others
Reply Quote Save Share Report
pete_manc_UK
Senior Member
1,234
5,678
Mar 2024
Manchester, UK
Oct 6, 2025 at 7:47 PM#40

A narrower follow-up, since the general answer is now clear:

Did your prescriber agree with that reading, and if not what was their objection?

Last edited: Oct 7, 2025 at 1:47 AM
25 0mike.trainer_LA, sarah_nash92, FitDadDave and 22 others
Reply Quote Save Share Report
1678

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register